bpc-157 legal status united states 2025 FDA panel votes to place popular peptide on compounding list BPC-157 FDA Approval Status 2026:

The compound shows high enzymatic selectivity, preserves lean mass, and engages longevity-related pathways (e.g., SIRT1), but remains a nonFDA-approved research substance that is WADA-banned and should be used under medical guidance

A Reliable Choice for Scientific Exploration With a focus on maintaining the integrity of your experiments, this peptide is rigorously tested and manufactured in state-of-the-art facilities, adhering to the highest scientific standards

(2019a)

Testing Free Ship Same Day Batch B002 Batch Documentation Current batch status Batch B002 Testing In Progress Independent analytical testing is in progress Results will be posted once finalized Independent analytical testing is taking longer than expected